These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3286182)

  • 41. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.
    Versluis DJ; Ten Kate FJ; Wenting GJ; Jeekel J; Weimar W
    J Clin Pathol; 1988 May; 41(5):498-503. PubMed ID: 3290264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclosporin A.
    Brünisholz MC; Bailey RR
    N Z Med J; 1985 Nov; 98(790):948-50. PubMed ID: 3909019
    [No Abstract]   [Full Text] [Related]  

  • 43. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 44. Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplanted recipients.
    Xu F; Huang JB; Jiang L; Xu J; Mi J
    Nephrol Dial Transplant; 1995; 10(1):142-3. PubMed ID: 7724020
    [No Abstract]   [Full Text] [Related]  

  • 45. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 46. [Postmortem study of renal lesions in 4 recipients of liver transplants treated with cyclosporin A].
    Carrera M; Griñó JM; Castelao AM; Galofré E; Soler T; Margarit J
    Med Clin (Barc); 1987 Dec; 89(20):866-9. PubMed ID: 3329277
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of cyclosporine-induced nephrotoxicity by immunoperoxidase analysis of renal allograft biopsies.
    Kolbeck PC; Wolfe JA; Burchette J; Sanfilippo F
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1781-4. PubMed ID: 3547883
    [No Abstract]   [Full Text] [Related]  

  • 48. Brief review of the morphology of ciclosporin nephropathy.
    Mihatsch MJ; Thiel G; Ryffel B
    Contrib Nephrol; 1987; 55():136-41. PubMed ID: 3549146
    [No Abstract]   [Full Text] [Related]  

  • 49. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 50. Complications of cyclosporin therapy.
    Kahan BD; Flechner SM; Lorber MI; Jensen C; Golden D; Van Buren CT
    World J Surg; 1986 Jun; 10(3):348-60. PubMed ID: 3524023
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of cyclosporine-induced nephrotoxicity with transdermal clonidine.
    Luke J; Luke DR; Williams LA; LeMaistre CF; Yau JC
    Clin Pharm; 1990 Jan; 9(1):49-53. PubMed ID: 2302930
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of 99Tcm radionuclides to show nephrotoxicity of cyclosporin A in transplanted kidneys.
    Thomsen HS; Munck O
    Acta Radiol; 1987; 28(1):59-61. PubMed ID: 3032224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
    Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
    Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cyclosporin A in liver transplantation].
    Pichlmayr R; Ringe B; Wonigeit K
    Internist (Berl); 1985 Sep; 26(9):553-6. PubMed ID: 3905676
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity.
    Mobb GE; Whiting PH; Feehally J; Veitch PS; Bell PR
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1241-3. PubMed ID: 1824892
    [No Abstract]   [Full Text] [Related]  

  • 56. Interstitial fibrosis in renal allografts in patients treated with cyclosporin.
    Farnsworth A; Hall BM; Duggin GG; Horvath JS; Tiller DJ
    Lancet; 1984 Dec; 2(8417-8418):1470-1. PubMed ID: 6151077
    [No Abstract]   [Full Text] [Related]  

  • 57. Ultrastructural renal findings in allografted kidneys of patients treated with ciclosporin A.
    Sacchi G; Benetti A; Falchetti M; Grigolato P; Cristinelli L; Strada A; Maiorca R
    Appl Pathol; 1987; 5(2):101-7. PubMed ID: 3307846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experience with cyclosporin/prednisolone therapy in kidney transplantation, with special reference to nephrotoxicity, ATN and kidney preservation.
    Pichlmayr R; Wonigeit K; Klempnauer J; Ringe B; Bunzendahl H; Kreller H; Heigel B; Siegismund S
    Neth J Med; 1985; 28(6):268-71. PubMed ID: 3892330
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of ultrasound in the diagnosis of cyclosporine toxicity in renal transplantation.
    Bergren CT; Toledo-Pereyra LH; Craig BM; Fawcett KJ
    Bol Asoc Med P R; 1986 Feb; 78(2):50-4. PubMed ID: 3518734
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
    Hamilton DV; Carmichael DJ; Evans DB; Calne RY
    Transplant Proc; 1982 Sep; 14(3):597-600. PubMed ID: 6758243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.